Jane Street
CLOV icon

Jane Street’s Clover Health Investments CLOV Stock Holding History

Jane Street’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.77M Buy
1,291,443
+250,039
+24% +$849K ﹤0.01% 3303
2026
Q1 		$1.83M Buy
1,041,404
+454,907
+78% +$987K ﹤0.01% 5261
2025
Q4 		$1.38M Sell
586,497
-1,380,091
-70% -$3.77M ﹤0.01% 5496
2025
Q3 		$6.02M Buy
1,966,588
+1,492,713
+315% +$4.26M ﹤0.01% 3148
2025
Q2 		$1.32M Sell
473,875
-854,137
-64% -$2.81M ﹤0.01% 5106
2025
Q1 		$4.77M Buy
1,328,012
+796,014
+150% +$3.2M ﹤0.01% 3005
2024
Q4 		$1.68M Buy
531,998
+235,595
+79% +$842K ﹤0.01% 4437
2024
Q3 		$836K Sell
296,403
-903,930
-75% -$2.07M ﹤0.01% 6232
2024
Q2 		$1.48M Buy
1,200,333
+581,425
+94% +$522K ﹤0.01% 5041
2024
Q1 		$491K Sell
618,908
-636,449
-51% -$579K ﹤0.01% 6697
2023
Q4 		$1.2M Buy
1,255,357
+771,849
+160% +$758K ﹤0.01% 5246
2023
Q3 		$522K Sell
483,508
-506,125
-51% -$602K ﹤0.01% 6237
2023
Q2 		$888K Buy
989,633
+597,987
+153% +$530K ﹤0.01% 5398
2023
Q1 		$331K Sell
391,646
-2,244,687
-85% -$2.46M ﹤0.01% 7028
2022
Q4 		$2.45M Buy
2,636,333
+2,427,248
+1,161% +$3.24M ﹤0.01% 3536
2022
Q3 		$355K Sell
209,085
-289,997
-58% -$760K ﹤0.01% 7308
2022
Q2 		$1.07M Buy
499,082
+2,194
+0.4% +$5.83K ﹤0.01% 5366
2022
Q1 		$1.76M Sell
496,888
-1,135,594
-70% -$3.29M ﹤0.01% 4985
2021
Q4 		$6.07M Buy
1,632,482
+1,342,760
+463% +$8.24M ﹤0.01% 2554
2021
Q3 		$2.14M Sell
289,722
-405,947
-58% -$3.47M ﹤0.01% 4344
2021
Q2 		$9.27M Buy
695,669
+37,915
+6% +$372K ﹤0.01% 1808
2021
Q1 		$4.97M Sell
657,754
-370,645
-36% -$4.18M ﹤0.01% 2421
2020
Q4 		$17.2M Buy
+1,028,399
New +$11.4M 0.01% 965

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jane Street's CLOV Position: Q2 2026 in Review

Jane Street increased its Clover Health Investments (CLOV) stake by 24% in Q2 2026, buying an estimated $849K and bringing the position to 1,291,443 shares worth $6.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3303.

Jane Street first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $17.2M in Q4 2020. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Jane Street held 1,291,443 shares of Clover Health Investments worth $6.77M as of Q2 2026.
  • Jane Street bought 250,039 Clover Health Investments shares in Q2 2026, an estimated $849K.
  • Clover Health Investments made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3303 holding.
  • Jane Street first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Jane Street's Clover Health Investments position peaked at $17.2M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.